WuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO), providing comprehensive, integrated solutions for the discovery, development, and production of biologics. With a presence in key international markets and cutting-edge facilities, WuXi Biologics empowers pharmaceutical and biotech partners to bring biologics to market faster, cost-effectively, and with regulatory confidence.

From early-stage discovery and cell line development to clinical and commercial manufacturing, WuXi Biologics offers flexible, scalable, and high-quality biologics services tailored to each project. The company emphasizes innovation, digital transformation, and sustainability, supporting a global client base across biologics, biosimilars, and advanced therapeutics.

Trusted for scientific expertise and operational excellence, WuXi Biologics continues to transform the biologics development landscape, accelerating timelines and enabling global access to life-saving therapies.